Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03808675 · ClinicalTrials.gov registry record · NA

Aerobic Exercise in Parkinson's Disease

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
57
Enrollment target

NCT03808675: Completed NA study, sponsored by VA Office of Research and Development.

NCT03808675 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03808675, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target

Study Summary

Parkinson's disease (PD) is an incurable brain illness that afflicts more than one million Americans, including many aging Veterans. PD places an unbearable burden on the individual due to progressive impairment of movement and mental function. As a result, patients lose critical abilities such as driving and can become isolated. Although drugs and surgery help movement problems, their benefits are temporary and may cause side effects. Drugs provide limited and temporary benefit for cognition and do not prevent dementia. Animal and preliminary human studies on aerobic exercise show promising results in helping a broad spectrum of symptoms. However, due to limited and inconsistent research results, the long term effects of aerobic exercise on brain health and clinical features in PD is unknown. The investigators will conduct a clinical trial to test the long term effects of aerobic exercise on the brain tissue, movement, mental functions, and driving in PD. If effective, aerobic exercise can be implemented immediately as a low cost, easily accessible treatment in PD.

Interventions

  • BEHAVIORAL Aerobic walking
  • BEHAVIORAL Usual care with PD specific health education

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2019-07-01
Est. Completion 2024-09-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT03808675

The ClinicalTrials.gov registry entry for NCT03808675 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Aerobic walking is the first listed.

NCT03808675 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03808675 about?

NCT03808675 is a clinical study titled "Aerobic Exercise in Parkinson's Disease". Parkinson's disease (PD) is an incurable brain illness that afflicts more than one million Americans, including many aging Veterans. PD places an unbearable burden on the individual due to progressive impairment of movement and mental function. As a result, patients lose critical abilities such as d...

What is the current status of trial NCT03808675?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2019-07-01. Estimated completion is 2024-09-30.

What interventions are being tested in trial NCT03808675?

The interventions under investigation include: Aerobic walking (BEHAVIORAL), Usual care with PD specific health education (BEHAVIORAL).

Who is sponsoring clinical trial NCT03808675?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.